Furthermore, NEAT1, MALAT1, XIST, and PKD had reported or validated having a close relation with pro chemotherapy resistance of malignant tumors (Gutschner et al., 2013; Hu et al., 2017; Kim et al., 2018; Li et al., 2018; Shan et al., 2020). Here, XIST is linked to cancer.